The ELISPOT assay is designed to enumerate cytokine producing cells in a single cell suspension. This method has the advantage of requiring a minimum of in-vitro manipulations allowing cytokine production analysis as close as possible to in-vivo conditions in a highly specific way. This technique is designed to determine the frequency of cytokine producing cells under a given stimulation, and the follow-up of such frequency during a treatment and/or a pathological state. Elispot assay constitutes an ideal tool in the TH1 / TH2 response, vaccine development, viral infection monitoring and treatment, oncology, infectious diseases, autoimmune diseases and transplantation.
This Elispot assay is based on sandwich immuno-enzyme technology. Cell secreted cytokines or soluble molecules are captured by coated antibodies avoiding diffusion in supernatant, protease degradation or binding on soluble membrane receptors. After cell removal, the captured cytokines are revealed by tracer antibodies and appropriate conjugates.
|Components||5 x 96 tests||10 x 96 tests||1 x 96 tests|
|Anti-FITC antibody green fluorescence conjugate.||1 vial||1 vial||1 vial|
|Biotinylated detection antibody for IL-2 (resuspend in 0.55mL).||1 vial||2 vials||1 vial|
|Bovine Serum Albumin||1 x 2g||2 x 2g||1 x 2g|
|FITC conjugated detection antibody for IFNg (resuspend in 0.55mL)||1 vial||2 vials||1 vial|
|Fluorescence buffer||1 x 2.5ml||2 x 2.5ml||1 x 0.6ml|
|Human IFN Gamma Capture antibody||1 x 500µl||2 x 500µl||1 x 100µl|
|Human IL-2 Capture antibody||1 x 500µl||2 x 500µl||1 x 100µl|
|Streptavidin-phycoerythrin conjugate.||1 vial||1 vial||1 vial|
Our Abpromise guarantee covers the use of ab48452 in the following tested applications.
|FluroSpot||Use at an assay dependent dilution.|
ab48452 has not yet been referenced specifically in any publications.